Vitamin K2 Administration Improves the Prognoses of Patients with Hepatocellular Carcinoma Presenting High Levels of Serum Des-γ-Carboxy Prothrombin
Background: Patients with hepatocellular carcinoma frequently develop portal venous invasion, a diagnosis of which affects patient prognosis. We have already shown the close association between the development of portal venous invasion and serum des-y-carboxy prothrombin levels in patients with hepatocellular carcinoma (Figure 1) . In addition, it has been reported that vitamin K2 administration decreases serum des-y-carboxy prothrombin levels in hepatocellular carcinoma patients and inhibits the proliferation of hepatocellular.
KeywordsHepatocellular Carcinoma Hepatocellular Carcinoma Cell Viral Hepatitis Tyrosine Phosphorylation Cell Growth Inhibition
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
© Springer Japan 2004